Shanghai RAAS Blood Products Co., Ltd.
002252
Rang in Aktien
#3554
Shanghai RAAS Blood Products Co., Ltd. engages in the research, development,... Shanghai RAAS Blood Products Co., Ltd. engages in the research, development, production, and sale of blood products. It provides human albumin, intravenous injection of human immunoglobulin, coagulation factor products, vaccines, diagnostic reagents, and testing services. The company was founded by Kieu Hoang on October 29, 1988 and is headquartered in Shanghai, China.
Aktienkurs
$0.7157778
Marktkapitalisierung
$4.72B
Veränderung (1 Tag)
-1.44%
Veränderung (1 Jahr)
-23.98%
Land
CN
Handel Shanghai RAAS Blood Products Co., Ltd. (002252)
Kategorie
Healthcare
Kursverlauf für Shanghai RAAS Blood Products Co., Ltd. (002252)
Höchster Schlusskurs: $0.72 am 2026-10-01
Niedrigster Schlusskurs: $0.31 am 2008-06-01
Niedrigster Schlusskurs: $0.31 am 2008-06-01
Kursverlauf der Aktie von Shanghai RAAS Blood Products Co., Ltd. von 2008 bis 2026
Jährliche Kursentwicklung
| Jahr | Leistung |
|---|---|
| 2026 (TTM) | -10.94% |
| 2025 | -9.89% |
| 2024 | -10.82% |
| 2023 | 37.89% |
| 2022 | -19.09% |
| 2021 | -14.15% |
| 2020 | 14.88% |
| 2019 | -39.74% |
| 2018 | -42.57% |
| 2017 | -5.12% |
| 2016 | -8.73% |
| 2015 | 68.38% |
| 2014 | 1.42% |
| 2013 | 244.29% |
| 2012 | 1.81% |
| 2011 | -31.43% |
| 2010 | 83.78% |
| 2009 | 43.19% |
| 2008 | 0.00% |
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
| Unternehmen | Aktienkurs | Veränderung 1J% | Land |
|---|---|---|---|
| $536.13 | 25.72% |
US
|
|
| $200.12 | 645.31% |
US
|
|
| $137.83 | -3.78% |
AU
|
|
| $291.76 | 2.51% |
BE
|
|
| $880.01 | 8.09% |
NL
|
